Nathalie Goulet: ‘We Have to Look at Saudi Arabia As Exceptional Partner’

Nathalie Goulet with Saudi Crown Prince Mohammed bin Salman during her visit to Riyadh earlier.
Nathalie Goulet with Saudi Crown Prince Mohammed bin Salman during her visit to Riyadh earlier.
TT

Nathalie Goulet: ‘We Have to Look at Saudi Arabia As Exceptional Partner’

Nathalie Goulet with Saudi Crown Prince Mohammed bin Salman during her visit to Riyadh earlier.
Nathalie Goulet with Saudi Crown Prince Mohammed bin Salman during her visit to Riyadh earlier.

Chairman of Parliamentary Group of France and the Gulf Countries and member of the French Senate Nathalie Goulet knows closely Gulf countries since and has visited them all many times, especially Saudi Arabia.

In her interview with Asharq Al-Awast, Goulet presented her vision of Saudi Arabia and stressed the importance of understanding the modernization and openness steps taken by the Saudi leadership and France's need to respond to them.

When asked about the years of strategic partnership between Saudi Arabia and France and how to assess them, Goulet said that these relations are excellent as there have been strategic partnerships in political, military and economic fields.

“Beyond talking about the contracts and numbers, I think that Saudi Arabia is facing strategic sectoral challenges such as sustainable development, sports, youth and tourism... In these sectors, France has extensive and recognized expertise and therefore can benefit the Kingdom and push these relations forward,” Goulet explained.

She also talked about the current bilateral cooperation in the war on terror and money laundering. “I had the honor to contribute to this cooperation,” she said.

In this context, Goulet added that a Saudi delegation that recently visited Paris held a series of meetings with a number of concerned financial institutions.

She stressed that the visit reflects the political will to combat terrorism, calling on all parties to let go of the stereotypes against Saudi Arabia and look at this country objectively.

“If I have the opportunity to say a final word about the Kingdom of Saudi Arabia, it is the following,” Goulet said, explaining that “after two years Saudi Arabia will be chairing the G-20 summit, and today we must consider it as an exceptional partner and be proactive in its openness and development, including the social reforms on which it has been working.”

“In societal matters, we must always bear in mind that the Kingdom of Saudi Arabia is guarding the two holy mosques, and it applies the basic rules of Islamic law.”

“We must respect the sovereignty of states, but this does not prevent us from expressing our opposition to the death penalty,” Goulet stressed.

Responding to a question in regards to the visit’s political aspects, especially the tense areas in the region, including the situation in Syria and Iraq, the war in Yemen and the conflict with Iran, and whether Saudi Arabia and France share a common vision, Goulet said that this common vision is available indeed, especially on regional issues.

“Perhaps the launching of Iranian missiles on Saudi territories shows how urgent the security issue is in this region, and how important it is to take it into consideration along with the Iranian policy.

Asharq Al-Awsat asked Goulet if she considered the nuclear agreement with Iran, which Riyadh firmly rejects, an obstacle to the strengthening of Saudi-French relations. She responded by saying that one of the constants of French diplomacy is that Paris speaks to everyone. “But the recent visit of Foreign Minister Jean-Yves Le Drian to Tehran showed the limited rapprochement between the two countries, which would be difficult to overcome”.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.